Elevance Health Inc.ELVNYSE
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+10.7%
5Y CAGR+10.4%
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+10.7%/yr
vs +21.7%/yr prior
5Y CAGR
+10.4%/yr
Consistent
Acceleration
-10.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
9 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$42.79B+6.0%
2024$40.35B+5.5%
2023$38.27B+21.5%
2022$31.50B+16.5%
2021$27.05B+3.6%
2020$26.11B+66.4%
2019$15.69B+9.2%
2018$14.37B+12.1%
2017$12.82B+0.7%
2016$12.72B-